InvestSMART

ImExHS Limited (ASX:IME)

ALERT: Price-sensitive ASX Announcement for IME
Current share price for IME : $0.320 -0.04 (-11.11%)+
Announcement
Release
25 May 2026 10:36AM
Price at Release
$0.360
Full Release
download
Summary
IMEXHS Limited announced winning a public tender for the deployment of its Aquila+ platform across 20 hospitals and clinics in Zacatecas, Mexico. This contract, secured through their distributor partner GOBA, will contribute approximately $384,000 in annual recurring revenue along with a $50,000 implementation fee. The deployment includes IMEXHS's five proprietary AI workflow agents and diagnostic algorithms from Gleamer, marking one of the most comprehensive AI-integrated radiology deployments. The rollout is expected to be completed by June 2026, with full revenue impact expected by September 2026. This contract is a significant step in IMEXHS's strategic expansion in Mexico and demonstrates their capacity to win in public sector procurement.
Key Points
  • IMEXHS won a public tender in Zacatecas, Mexico.
  • The contract includes deployment in 20 hospitals and clinics.
  • $384,000 in new annual recurring revenue plus $50,000 implementation fee.
  • Involves AI workflow agents and Gleamer diagnostic algorithms.
  • Implementation will be completed by June 2026.
  • Full revenue impact expected by September 2026.
  • Expands IMEXHS's presence in Mexico.
  • Highlights company's competitive edge in public sector procurement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.